aDivision of Pulmonology, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, CA, USA bJoint Program in Computational Precision Health, ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

1 Department of Neurology, Massachusetts General Hospital (MGH), Boston, MA, USA. 2 Clinical Data Animation Center (CDAC), Harvard Medical School, Boston, MA, USA. 3 ...

The following is a summary of “Respiratory effects of prone position in COVID-19 acute respiratory distress syndrome differ according to the recruitment-to-inflation ratio: a prospective observational ...

The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.

Introduction The use of fibrinolytic therapy has been proposed in severe acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, anticoagulation has received special attention due to ...

ABSTRACT: Background: Recombinant human soluble thrombomodulin (rhTM) was approved for the treatment of disseminated intravascular coagulation in Japan, and rhTM has anti-inflammatory effects.

The PF ratio (PaO2/FiO2 ratio) is an essential indicator used in medicine to gauge the severity of a patient’s hypoxemic respiratory failure. This value helps healthcare professionals determine ...

The P/F ratio, also known as the PaO2/FiO2 ratio, is a valuable tool for evaluating oxygenation status in critically ill patients. It is commonly used to determine the severity of acute respiratory ...